Principia Sanitatis: The Mathematical Principles of Human Longevity (Volume IV: Biomarkers & Interventions): Measurement and Modification of the Biological State

VOLUME IV: BIOMARKERS & INTERVENTIONS: ESCAPING THE THEOREMThe transition from theoretical possibility (C1–C6) to clinical reality. Volume IV catalogues the toolkit required to move the biological state vector: Observability (C1) and Controllability (C2).BOOK X: BIOMARKERS (OBSERVABILITY MAP)Systematic evaluation of every available tool for Actionable State Vector Estimation. Defines the Minimum Viable Monitoring Panel.Energetic Dimension: NAD+ quantification (whole blood, intracellular, organ-specific), evaluated for sensitivity, reliability, and cost-accessibility tradeoffs.Clearance Dimension: Autophagy flux assays (LC3-II/I ratio, p62 accumulation), with critical assessment of measurement maturity versus inadequacy.Senescent Dimension: SA-β-gal, p16INK4a expression, SASP profiling, and circulating biomarker panels, focused on estimating systemic senescent burden without tissue biopsy.Regenerative Dimension: Colony-forming unit counts, telomere distributions, and clonal hematopoiesis detection, used to assess functional regenerative capacity across tissue types.Programmatic Dimension: Epigenetic clocks (GrimAge, PhenoAge, DunedinPACE), evaluated not as age predictors but as real-time monitors of the Programmatic State.Functional Dimension: Composite indices (VO2max, grip strength, renal and hepatic clearance) integrating organ-level performance metrics.BOOK XI: INTERVENTIONS (CONTROLLABILITY MAP)The pharmacological and therapeutic arsenal mapped directly to state space dimensions. Every intervention is evidence-graded and aligned with the Sequential Maintenance Law derived in Volume III.Energetic Interventions: NMN, NR, CD38 inhibitors, analyzed via dose–response curves, bioavailability data, and preclinical/clinical evidence grading.Clearance Interventions: Rapamycin, spermidine, fasting protocols, TFEB activators, with emphasis on the dose–timing–duration relationship that determines whether mTORC1 inhibition enhances or impairs clearance.Senescent Interventions: Dasatinib+Quercetin, fisetin, navitoclax, and targeted approaches, distinguishing senolytic (killing) from senomorphic (suppressing) strategies, with attention to tissue specificity.Regenerative Interventions: Growth factors, stem cell mobilization, exosomes, and tissue engineering, mapped to functional regenerative capacity.Programmatic Interventions: Partial Yamanaka factor expression and chemical reprogramming cocktails, subjected to rigorous risk–benefit analysis balancing rejuvenation against the risk of dedifferentiation.SYNTHESIS: NONLINEAR CONTROLEach intervention is graded on a five-point scale and tracked for primary and secondary state effects.Flagged risks: interventions that improve one variable while simultaneously degrading another.Synergy mapping: combinations that produce nonlinear benefits.Ordering principle: placement of all therapies within the mandated sequence of the Sequential Maintenance Law.The instruments for measurement and the control levers for manipulation are now catalogued, graded, and precision-mapped to the mathematical framework, setting the stage for Volume V’s operational clinical protocol. Read more